Activity of cabazitaxel in metastatic or inoperable locally advanced dedifferentiated liposarcoma: a phase 2 study of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG)

This phase 2 nonrandomized clinical trial examines the association of cabazitaxel treatment for patients with advanced dedifferentiated liposarcoma with progression-free survival.

Saved in:

Bibliographic Details
Main Authors:	Sanfilippo, Roberta (Author) , Hayward, Richard L. (Author) , Musoro, Jammbe (Author) , Benson, Charlotte (Author) , Leahy, Michael Gordon (Author) , Brunello, Antonella (Author) , Blay, Jean-Yves (Author) , Steeghs, Neeltje (Author) , Desar, Ingrid M. E. (Author) , Ali, Nasim (Author) , Hervieu, Alice (Author) , Thway, Khin (Author) , Marreaud, Sandrine (Author) , Litiere, Saskia (Author) , Kasper, Bernd (Author)
Format:	Article (Journal)
Language:	English
Published:	August 18, 2022
In:	JAMA oncology Year: 2022, Volume: 8, Issue: 10, Pages: 1420-1425
ISSN:	2374-2445
DOI:	10.1001/jamaoncol.2022.3218
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/jamaoncol.2022.3218 Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389439/
Author Notes:	Roberta Sanfilippo, Richard L. Hayward, Jammbe Musoro, Charlotte Benson, Michael Gordon Leahy, Antonella Brunello, Jean-Yves Blay, Neeltje Steeghs, Ingrid M. E. Desar, Nasim Ali, Alice Hervieu, Khin Thway, Sandrine Marreaud, Saskia Litiere, and Bernd Kasper

Description
Summary:	This phase 2 nonrandomized clinical trial examines the association of cabazitaxel treatment for patients with advanced dedifferentiated liposarcoma with progression-free survival.
Item Description:	Gesehen am 22.08.2023
Physical Description:	Online Resource
ISSN:	2374-2445
DOI:	10.1001/jamaoncol.2022.3218